Showing results (1371-1380 of 1,526) with videos related to

Sort By:
Pageof 153
The Journal of Pediatrics|June 26, 2007
Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxideSusan R Hintz, Krisa P Van Meurs, R Perritt, et al.
Infection Control and Hospital Epidemiology|March 20, 2018
Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort StudyMini Kamboj, Teresa Childers, Jessica Sugalski, et al.
Mbio|January 23, 2024
A CO2 sensing module modulates β-1,3-glucan exposure in Candida albicansGabriela M Avelar, Arnab Pradhan, Qinxi Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2024
Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respirationSoah Lee, Alison S Vander Roest, Cheavar A Blair, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 8, 2014
Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence baseRichard D Feinman, Wendy K Pogozelski, Arne Astrup, et al.
Plos One|May 25, 2012
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia veraManfred Kraus, Yuxun Wang, Dan Aleksandrowicz, et al.
Science Translational Medicine|January 24, 2014
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathyMartin K Childers, Romain Joubert, Karine Poulard, et al.
HGG Advances|August 25, 2024
LARP1 haploinsufficiency is associated with an autosomal dominant neurodevelopmental disorderJames Chettle, Raymond J Louie, Olivia Larner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2017
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in DogsDavid L Mack, Karine Poulard, Melissa A Goddard, et al.
Molecular Cancer Therapeutics|December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative StressMarissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Pageof 153